Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS (2021) Liver cirrhosis. Lancet 398(10308):1359–1376

Article  PubMed  Google Scholar 

Novo E, Bocca C, Foglia B, Protopapa F, Maggiora M, Parola M et al (2020) Liver fibrogenesis: un update on established and emerging basic concepts. Arch Biochem Biophys 689:108445

Article  CAS  PubMed  Google Scholar 

GBD 2017 Causes of Death Collaborators (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1736–1788

Article  Google Scholar 

Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J et al (2014) Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med 12:145

Article  PubMed  PubMed Central  Google Scholar 

Rastogi A, Maiwall R, Bihari C, Ahuja A, Kumar A, Singh T et al (2013) Cirrhosis histology and Laennec staging system correlate with high portal pressure. Histopathology 62(5):731–741

Article  PubMed  Google Scholar 

Sethasine S, Jain D, Groszmann RJ, Garcia-Tsao G (2012) Quantitative histological-hemodynamic correlations in cirrhosis. Hepatology 55(4):1146–1153

Article  PubMed  Google Scholar 

Wang W, Li J, Pan R, Sileng A, Liao C (2015) Association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function. Hepatol Int 9(4):621–626

Article  CAS  PubMed  Google Scholar 

Gu J, Zhang E, Liang B, Zhang Z, Chen X, Xiong M et al (2021) Liver Collagen Contents Are Closely Associated with the Severity of Cirrhosis and Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma and Child-Pugh Grade A Liver Function. Ann Surg Oncol 28(8):4227–4235

Article  PubMed  Google Scholar 

Israelsen M, Guerrero Misas M, Koutsoumourakis A, Huang Y, Thiele M, Hall A et al (2020) Collagen proportionate area predicts clinical outcomes in patients with alcohol-related liver disease. Aliment Pharmacol Ther 52(11–12):1728–1739

Article  CAS  PubMed  Google Scholar 

Joo I, Lee JM, Yoon JH, Jang JJ, Han JK, Choi BI (2014) Nonalcoholic fatty liver disease: intravoxel incoherent motion diffusion-weighted MR imaging-an experimental study in a rabbit model. Radiology 270(1):131–140

Article  PubMed  Google Scholar 

Hu G, Chan Q, Quan X, Zhang X, Li Y, Zhong X et al (2015) Intravoxel incoherent motion MRI evaluation for the staging of liver fibrosis in a rat model. J Magn Reson Imaging 42(2):331–339

Article  PubMed  Google Scholar 

Garbuzenko DV, Arefyev NO, Kazachkov EL (2018) Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives. World J Gastroenterol 24(33):3738–3748

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, Fernandez M (2009) Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 49(4):1245–1256

Article  CAS  PubMed  Google Scholar 

Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H (2010) New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol 53(1):132–144

Article  CAS  PubMed  Google Scholar 

Chen YL, Lv J, Ye XL, Sun MY, Xu Q, Liu CH et al (2011) Sorafenib inhibits transforming growth factor β1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes. Hepatology 53(5):1708–1718

Article  CAS  PubMed  Google Scholar 

Qin S, Bi F, Gu S, Bai Y, Chen Z, Wang Z et al (2021) Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial. J Clin Oncol 29:JCO2100163

Google Scholar 

Zhong L, Hou C, Zhang L, Zhao J, Li F, Li W (2019) Synthesis of deuterium-enriched sorafenib derivatives and evaluation of their biological activities. Mol Divers 23(2):341–350

Article  CAS  PubMed  Google Scholar 

Hamdy N, El-Demerdash E (2012) New therapeutic aspect for carvedilol: antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage. Toxicol Appl Pharmacol 261(3):292–299

Article  CAS  PubMed  Google Scholar 

Königshofer P, Brusilovskaya K, Schwabl P, Reiberger T (2019) Animal models of portal hypertension. Biochim Biophys Acta Mol Basis Dis 1865(5):1019–1030

Article  PubMed  Google Scholar 

Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168(2):497–505

Article  PubMed  Google Scholar 

Turner R, Le Bihan D, Maier J, Vavrek R, Hedges LK, Pekar J (1990) Echo-planar imaging of intravoxel incoherent motion. Radiology 177(2):407–414

Article  CAS  PubMed  Google Scholar 

Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349(9055):825–832

Article  CAS  PubMed  Google Scholar 

Ogawa H, Kaji K, Nishimura N, Takagi H, Ishida K, Takaya H et al (2021) Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis. J Cell Mol Med 25(8):4001–4013

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, Li Z, Xiu AY, Meng DX, Wang SN, Zhang CQ (2019) Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice. Drug Des Devel Ther 13:2667–2676

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ling L, Li G, Wang G, Meng D, Li Z, Zhang C (2019) Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis. Mol Med Rep 20(2):1605–1612

CAS  PubMed  PubMed Central  Google Scholar 

Chow AM, Gao DS, Fan SJ, Qiao Z, Lee FY, Yang J et al (2012) Liver fibrosis: an intravoxel incoherent motion (IVIM) study. J Magn Reson Imaging 36(1):159–167

Article  PubMed  Google Scholar 

Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Enomoto N et al (2015) MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography. J Magn Reson Imaging 42(1):204–210

Article  PubMed  Google Scholar 

Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD (2009) American Association for the Study of Liver Diseases. Liver biopsy Hepatology 49(3):1017–1044

Article  PubMed  Google Scholar 

Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C et al (2020) Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut 69(8):1382–1403

Article  PubMed  Google Scholar 

Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. SHARP Investigators Study Group. (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 359(4):378–90.

Zhao D, Chen J, Long X, Wang J (2021) Dose adjustment for tyrosine kinase inhibitors in non-small cell lung cancer patients with hepatic or renal function impairment (Review). Oncol Rep 45(2):413–426

Article  CAS  PubMed  Google Scholar